ULTRAGENYX Trademark

Trademark Overview

On Monday, April 8, 2013, a trademark application was filed for ULTRAGENYX with the United States Patent and Trademark Office. The USPTO has given the ULTRAGENYX trademark a serial number of 85898417. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, June 29, 2023. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The ULTRAGENYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
ultragenyx

General Information

Serial Number85898417
Word MarkULTRAGENYX
Filing DateMonday, April 8, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, June 29, 2023
Registration Number5124554
Registration DateTuesday, January 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
Pseudo MarkULTRA GENYX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2013
Primary Code005
First Use Anywhere DateMonday, May 23, 2011
First Use In Commerce DateMonday, May 23, 2011

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Tuesday, July 23, 2013NON-FINAL ACTION E-MAILED
Thursday, April 11, 2013NEW APPLICATION ENTERED
Monday, April 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 16, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, July 22, 2013ASSIGNED TO EXAMINER
Tuesday, July 23, 2013NON-FINAL ACTION WRITTEN
Tuesday, July 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 20, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, August 20, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 20, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 8, 2013PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2013ASSIGNED TO LIE
Tuesday, September 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 28, 2015SOU EXTENSION 2 GRANTED
Tuesday, October 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 2, 2014SOU TEAS EXTENSION RECEIVED
Monday, June 2, 2014SOU EXTENSION 1 FILED
Monday, June 2, 2014SOU EXTENSION 1 GRANTED
Wednesday, June 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 2, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, December 2, 2014SOU EXTENSION 2 FILED
Wednesday, January 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 6, 2016SOU TEAS EXTENSION RECEIVED
Thursday, January 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 27, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, May 27, 2015SOU EXTENSION 3 FILED
Thursday, June 4, 2015SOU EXTENSION 3 GRANTED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 13, 2015SOU TEAS EXTENSION RECEIVED
Friday, November 13, 2015SOU EXTENSION 4 FILED
Wednesday, January 13, 2016SOU EXTENSION 4 GRANTED
Thursday, January 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 6, 2016SOU EXTENSION 5 FILED
Saturday, May 21, 2016SOU EXTENSION 5 GRANTED
Tuesday, May 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2016TEAS STATEMENT OF USE RECEIVED
Monday, December 5, 2016USE AMENDMENT FILED
Tuesday, December 13, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 15, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 16, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 17, 2017REGISTERED-PRINCIPAL REGISTER
Friday, August 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 6, 2023TEAS SECTION 8 & 15 RECEIVED
Thursday, June 29, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 29, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 29, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ultragenyx lipid endocrine orthopedic related conditions disorders diseases metabolic oncologic genetic